Contact Information for Avelumab With Binimetinib, Utomilumab, or PF-04518600 For Advanced Triple Negative Breast Cancer
The sites for this trial are listed below.
If you speak with a site, please mention that you were referred by BreastCancerTrials.org
University of Alabama at Birmingham,
Birmingham,
AL,
35294
Principal Investigator: |
Ahmed Elkhanany, MD |
Contact person: |
Felicia Witherspoon |
Phone: | 205-934-4317 |
Email: |
fwithers@uab.edu |
University of California, San Francisco,
San Francisco,
CA,
94143
Contact person: |
Hope Rugo, MD |
Phone: | 877-827-3222 |
Email: |
cancertrials@ucsf.edu |
Georgetown University,
Washington,
DC,
20057
Principal Investigator: |
Filipa Lynce, MD |
Contact person: |
Antonella Novielli |
Phone: | 202-683-0716 |
Email: |
noviella@georgetown.edu |
University of Chicago Medicine Comprehensive Cancer Center,
Evergreen Park,
IL,
60805
Principal Investigator: |
Rita Nanda, MD |
Email: |
vqq5698@bsd.uchicago.edu |
Dana-Farber Cancer Institute,
Boston,
MA,
02215
Principal Investigator: |
Erica Mayer, MD MPh |
Contact person: |
Hannah Phelan |
Email: |
hannah_phelan@dfci.harvard.edu |
Mayo Clinic,
Rochester,
MN,
55905
Contact person: |
Minetta C. Liu |
Phone: | 507-293-0526 |
Email: |
liu.minetta@mayo.edu |
Duke Cancer Institute,
Durham,
NC,
27710
Principal Investigator: |
Susan Dent, MD, BSc |
Contact person: |
Caroline Morales |
Email: |
caroline.morales@duke.edu |
Baylor College of Medicine,
Houston,
TX,
77030
Principal Investigator: |
Valentina Hoyos Velez, MD |
Contact person: |
Chava Kankana |
Phone: | 713-798-1911 |
Email: |
Kankana.Chava@bcm.edu |